Market Analysis and Insights: Global MicroRNA Sequencing (miRNA-Seq) Market
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.
The global MicroRNA Sequencing (miRNA-Seq) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Sequencing by Synthesis accounting for % of the MicroRNA Sequencing (miRNA-Seq) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Academic & Research Institutes segment is altered to an % CAGR throughout this forecast period.
China MicroRNA Sequencing (miRNA-Seq) market size is valued at US$ million in 2021, while the North America and Europe MicroRNA Sequencing (miRNA-Seq) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe MicroRNA Sequencing (miRNA-Seq) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global MicroRNA Sequencing (miRNA-Seq) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global MicroRNA Sequencing (miRNA-Seq) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global MicroRNA Sequencing (miRNA-Seq) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global MicroRNA Sequencing (miRNA-Seq) market.
Global MicroRNA Sequencing (miRNA-Seq) Scope and Market Size
MicroRNA Sequencing (miRNA-Seq) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global MicroRNA Sequencing (miRNA-Seq) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
SOLiD
Nanopore Sequencing
Segment by Application
Academic & Research Institutes
CROs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Illumina
Thermo Fisher
Qiagen
Perkinelmer
Takara Bio
New England Biolabs
Norgen Biotek
Trilink Biotechnologies
Lexogen
Oxford Nanopore Technologies